0,827  0,004  GST A substrate
0,780  0,004  NOS3 expression inhibitor
0,755  0,002  Pneumotoxic
0,721  0,004  Carcinogenic, group 3
0,711  0,006  5 Hydroxytryptamine release stimulant
0,722  0,027  Apoptosis agonist
0,686  0,002  GST P1-1 substrate
0,683  0,014  CYP2C9 substrate
0,666  0,004  Carcinogenic, group 2B
0,671  0,010  CYP1A2 substrate
0,649  0,011  Sensitization
0,614  0,006  GABA C receptor rho-3 antagonist
0,595  0,006  FMO1 substrate
0,564  0,004  Growth hormone agonist
0,551  0,003  Porphobilinogen synthase inhibitor
0,563  0,016  CYP2D6 substrate
0,582  0,039  Caspase 9 stimulant
0,549  0,010  Skin irritative effect
0,534  0,002  Ferrochelatase inhibitor
0,550  0,020  Carcinogenic
0,534  0,006  Genotoxic
0,534  0,019  Antineoplastic (cervical cancer)
0,515  0,013  Eye irritation, high
0,523  0,021  Antineoplastic (melanoma)
0,527  0,035  Antileukemic
0,494  0,005  Glutathione S-transferase substrate
0,521  0,032  Antiprotozoal
0,497  0,013  Superoxide dismutase inhibitor
0,482  0,010  Radiosensitizer
0,494  0,021  Mutagenic
0,508  0,039  CYP3A4 substrate
0,468  0,005  GST M1-1 substrate
0,490  0,027  Antiprotozoal (Plasmodium)
0,483  0,023  Antineoplastic (pancreatic cancer)
0,502  0,045  Antineoplastic (lung cancer)
0,469  0,013  Sigma receptor agonist
0,463  0,009  Calcium channel activator
0,488  0,034  Teratogen
0,469  0,015  UGT1A6 substrate
0,457  0,006  5 Hydroxytryptamine uptake stimulant
0,468  0,020  Antiprotozoal (Leishmania)
0,447  0,004  Carcinogenic, group 1
0,460  0,018  UGT2B4 substrate
0,489  0,049  TNF expression inhibitor
0,495  0,055  Antineoplastic (breast cancer)
0,454  0,015  Antineoplastic enhancer
0,464  0,026  CTGF expression inhibitor
0,471  0,034  Embryotoxic
0,440  0,003  Phenylalanine 4-hydroxylase inhibitor
0,461  0,026  Chemoprotective
0,481  0,047  Transcription factor NF kappa B inhibitor
0,436  0,005  Interleukin 6 antagonist
0,460  0,038  Vasodilator, peripheral
0,429  0,011  FMO3 substrate
0,466  0,051  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,422  0,013  UGT1A4 substrate
0,433  0,024  Free radical scavenger
0,411  0,015  Flavin-containing monooxygenase substrate
0,428  0,033  Antineoplastic (brain cancer)
0,405  0,010  Phospholipase C inhibitor
0,400  0,009  Alpha-N-acetylglucosaminidase inhibitor
0,422  0,034  AR expression inhibitor
0,417  0,029  Antineoplastic (non-small cell lung cancer)
0,400  0,016  Antimutagenic
0,431  0,047  CYP2C19 inhibitor
0,438  0,056  Histamine release inhibitor
0,398  0,017  UGT1A1 substrate
0,402  0,035  Antioxidant
0,417  0,051  Ulceration
0,397  0,033  NOS2 expression inhibitor
0,403  0,044  Antifungal
0,395  0,037  Antineoplastic (glioma)
0,417  0,060  Antipruritic, allergic
0,375  0,020  Abortion inducer
0,399  0,047  Aldehyde oxidase inhibitor
0,356  0,009  Amyloid beta precursor protein antagonist
0,374  0,031  Cardiodepressant
0,347  0,005  Succinate dehydrogenase inhibitor
0,392  0,051  Cholesterol antagonist
0,375  0,034  DNA damaging
0,342  0,003  Biliverdin reductase inhibitor
0,357  0,021  ErbB-1 antagonist
0,379  0,044  CYP2C19 substrate
0,364  0,030  Nitric oxide antagonist
0,338  0,004  Carcinogenic, group 2A
0,362  0,035  Antihypoxic
0,354  0,028  Peroxidase inhibitor
0,332  0,007  Aldehyde oxidase substrate
0,348  0,024  Antiparkinsonian, rigidity relieving
0,355  0,034  Chemopreventive
0,398  0,078  Antibacterial
0,371  0,051  Antineoplastic (ovarian cancer)
0,330  0,011  CNS active muscle relaxant
0,324  0,005  Age-related macular degeneration treatment
0,397  0,080  5 Hydroxytryptamine release inhibitor
0,350  0,034  Antineoplastic (liver cancer)
0,412  0,098  Antineoplastic (solid tumors)
0,372  0,059  Antineoplastic (colorectal cancer)
0,362  0,051  Apoptosis antagonist
0,348  0,039  Cardiovascular analeptic
0,324  0,014  NOS3 expression enhancer
0,328  0,022  Tyrosine 3 hydroxylase inhibitor
0,335  0,030  Antihypertriglyceridemic
0,358  0,054  Respiratory analeptic
0,313  0,008  SULT1A3 substrate
0,304  0,007  Excitatory amino acid transporter EAAC1 inhibitor
0,335  0,039  Antineoplastic (glioblastoma multiforme)
0,301  0,005  Estrogen receptor beta antagonist
0,313  0,022  Contraceptive
0,311  0,023  5 Hydroxytryptamine 1E antagonist
0,344  0,058  Vasodilator, coronary
0,316  0,032  UDP-glucuronosyltransferase substrate
0,314  0,030  Sedative
0,304  0,024  VCAM1 expression inhibitor
0,285  0,007  Estrogen antagonist
0,284  0,007  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,295  0,021  Acaricide
0,321  0,047  Insulysin inhibitor
0,303  0,032  Anesthetic general
0,281  0,011  GABA C receptor agonist
0,275  0,005  Photosensitizer
0,338  0,070  Prostate cancer treatment
0,299  0,032  Muscle relaxant
0,274  0,008  GABA C receptor rho-2 antagonist
0,283  0,020  UGT2B15 substrate
0,265  0,005  Antiprotozoal (Babesia)
0,265  0,006  Triose-phosphate isomerase inhibitor
0,283  0,025  Antipruritic, non-allergic
0,280  0,025  Antiacne
0,307  0,052  Transcription factor STAT inhibitor
0,278  0,025  CYP2B6 inhibitor
0,317  0,065  Analeptic
0,260  0,009  Catenin beta inhibitor
0,319  0,069  Antineoplastic (colon cancer)
0,312  0,063  Radioprotector
0,251  0,003  Antidote, mercury
0,300  0,053  Transcription factor STAT3 inhibitor
0,259  0,013  5 Hydroxytryptamine 3E antagonist
0,301  0,056  Antipyretic
0,271  0,027  Antiviral (Hepatitis)
0,262  0,019  Cyclooxygenase 1 inhibitor
0,243  0,005  Protein kinase C delta inhibitor
0,277  0,039  Antihypotensive
0,241  0,004  Estrogen receptor beta agonist
0,264  0,027  Antihelmintic (Nematodes)
0,248  0,014  UGT2B10 substrate
0,383  0,150  Antiinflammatory
0,243  0,011  Antiprotozoal (Amoeba)
0,254  0,022  Antiviral (Hepatitis C)
0,303  0,072  Antineoplastic (endocrine cancer)
0,235  0,005  Adenylate cyclase stimulant
0,256  0,028  Skeletal muscle relaxant
0,259  0,030  Sepsis treatment
0,289  0,065  UGT1A9 substrate
0,243  0,020  Adenylate cyclase inhibitor
0,278  0,056  Vasodilator
0,226  0,004  Thioredoxin reductase inhibitor
0,230  0,008  GABA C receptor antagonist
0,276  0,056  Cytotoxic
0,307  0,089  Angiogenesis inhibitor
0,277  0,061  Proliferative diseases treatment
0,237  0,024  NADPH oxidase inhibitor
0,218  0,005  GST T1-1 substrate
0,267  0,054  Antiparasitic
0,228  0,015  Antirickettsial
0,223  0,011  Antispirochetal
0,237  0,026  Monophenol monooxygenase inhibitor
0,316  0,105  Immunosuppressant
0,278  0,067  Antihypercholesterolemic
0,264  0,054  Antiulcerative
0,241  0,031  Hair growth stimulant
0,222  0,012  Adenylate kinase inhibitor
0,265  0,057  Cyclic AMP phosphodiesterase inhibitor
0,271  0,064  Interleukin agonist
0,231  0,026  UGT2B9 substrate
0,249  0,045  Antihelmintic
0,225  0,022  Aldehyde dehydrogenase inhibitor
0,209  0,007  GABA C receptor rho-1 antagonist
0,233  0,032  Melanin inhibitor
0,264  0,063  Gastrin inhibitor
0,214  0,015  CF transmembrane conductance regulator agonist
0,243  0,044  Antiviral (West Nile virus)
0,234  0,035  UGT1A3 substrate
0,230  0,032  Prostate disorders treatment
0,239  0,041  Nitric-oxide synthase stimulant
0,228  0,030  Skin whitener
0,207  0,009  TRPA1 agonist
0,291  0,094  Antithrombotic
0,212  0,016  SULT1A1 substrate
0,213  0,017  Interleukin 1b antagonist
0,205  0,010  Antiviral (Influenza B)
0,225  0,030  Tubulin antagonist
0,218  0,024  Cell wall synthesis inhibitor
0,219  0,027  Uterine stimulant
0,228  0,036  Cytidine deaminase inhibitor
0,226  0,035  Amylase inhibitor
0,207  0,016  Cyclooxygenase 3 inhibitor
0,208  0,018  Microtubule formation inhibitor
0,215  0,026  MAO A inhibitor
0,280  0,092  12-Lipoxygenase inhibitor
0,210  0,022  Cystathionine beta-synthase inhibitor
0,222  0,034  Interferon gamma antagonist
0,213  0,027  Phobic disorders treatment
0,234  0,048  UGT2B7 substrate
0,219  0,035  MAO inhibitor
0,255  0,076  Antineoplastic (renal cancer)
0,206  0,029  Cocaine dependence treatment
0,246  0,069  DNA synthesis inhibitor
0,194  0,019  UDP-glucose 4-epimerase inhibitor
0,196  0,021  Shock treatment
0,204  0,030  Arachidonic acid antagonist
0,184  0,011  Vanilloid 1 antagonist
0,183  0,011  Electrolyte absorption antagonist
0,173  0,002  Estrogen-related receptor beta antagonist
0,186  0,015  Antihelmintic (Fasciola)
0,201  0,031  Antifungal enhancer
0,232  0,062  RNA-directed DNA polymerase inhibitor
0,192  0,023  Antifungal (Cryptococcus)
0,224  0,055  Non-steroidal antiinflammatory agent
0,180  0,012  Heat shock protein 70 antagonist
0,201  0,034  Neurotensin receptor agonist
0,232  0,065  Psychostimulant
0,259  0,093  Hypoxia-inducible factor 1 alpha inhibitor
0,195  0,030  Raynaud's phenomenon treatment
0,190  0,028  Toll-Like receptor 2 antagonist
0,172  0,011  Ca2+-transporting ATPase inhibitor
0,169  0,009  UGT2B11 substrate
0,200  0,041  Protein kinase stimulant
0,176  0,018  Papain-like protease (SARS coronavirus) inhibitor
0,207  0,049  Tumour necrosis factor antagonist
0,203  0,046  Antiviral (Herpes)
0,169  0,013  Toll-Like receptor 4 antagonist
0,213  0,058  Hepatoprotectant
0,180  0,026  Hearing loss treatment
0,182  0,029  Cathepsin H inhibitor
0,194  0,042  ATPase inhibitor
0,165  0,015  Phosphofructokinase-1 inhibitor
0,212  0,063  DNA methyltransferase I inhibitor
0,155  0,007  Nicotinic alpha4beta2 receptor antagonist
0,287  0,139  15-Lipoxygenase inhibitor
0,170  0,023  Gastritis treatment
0,177  0,029  Antibacterial (Helicobacter pylori)
0,155  0,007  GABA aminotransferase inhibitor
0,199  0,052  3C-like protease (Human coronavirus) inhibitor
0,166  0,020  HIV-1 integrase (Overall Integration) inhibitor
0,169  0,024  Vanilloid 1 agonist
0,220  0,076  Peptidyltransferase inhibitor
0,184  0,041  Antiseptic
0,239  0,097  CYP1A2 inhibitor
0,158  0,015  ABCA1 expression enhancer
0,153  0,011  Estrogen agonist
0,180  0,038  Antianemic
0,186  0,045  Anesthetic
0,153  0,012  Glutamate decarboxylase inhibitor
0,145  0,004  Estrogen-related receptor alpha antagonist
0,143  0,003  Anesthetic inhalation
0,159  0,020  Creatine kinase inhibitor
0,152  0,015  Acetylcholine release stimulant
0,153  0,016  Anabolic
0,205  0,068  Insulin sensitizer
0,231  0,095  Antiprotozoal (Trypanosoma)
0,151  0,016  Glutamate dehydrogenase inhibitor
0,208  0,074  DNA methylase inhibitor
0,138  0,004  Glucose-6-phosphate translocase inhibitor
0,169  0,036  Cholesterol synthesis inhibitor
0,181  0,048  Thiol protease inhibitor
0,150  0,016  CYP2A6 inhibitor
0,185  0,051  Antiviral (Influenza A)
0,153  0,021  Prolactin inhibitor
0,144  0,013  Ornithine decarboxylase inhibitor
0,204  0,073  Neurotrophic factor enhancer
0,195  0,064  VEGF expression inhibitor
0,148  0,018  NADH dehydrogenase inhibitor
0,156  0,026  Sulfotransferase substrate
0,158  0,029  NAT2 substrate
0,139  0,010  Acyl-CoA dehydrogenase inhibitor
0,143  0,014  Lanosterol 14 alpha demethylase inhibitor
0,132  0,004  Antidote, organophosphates
0,131  0,004  Factor III inhibitor
0,217  0,091  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,168  0,042  Movement disorders treatment
0,218  0,092  Neuropeptide Y2 antagonist
0,131  0,005  Potassium channel Kv1.3 blocker
0,214  0,088  Antiglaucomic
0,128  0,003  Adenylate cyclase 1 inhibitor
0,178  0,053  Antineoplastic (carcinoma)
0,243  0,119  Caspase 3 stimulant
0,147  0,023  Antifungal (Pneumocystis)
0,160  0,037  Pregnane X receptor agonist
0,176  0,053  Cyclooxygenase inhibitor
0,127  0,004  Exportin-1 inhibitor
0,228  0,106  Immunostimulant
0,153  0,031  Sphingosine 1-phosphate receptor 4 antagonist
0,140  0,018  Inducible nitric-oxide synthase inhibitor
0,225  0,103  Spasmolytic
0,127  0,005  Phospholipase D inhibitor
0,188  0,066  LDLR expression enhancer
0,263  0,142  Antineoplastic (non-Hodgkin's lymphoma)
0,162  0,041  Nav1.6 sodium channel blocker
0,130  0,010  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,200  0,081  Pyruvate kinase inhibitor
0,168  0,050  Mannose-6-phosphate isomerase inhibitor
0,151  0,033  Alcohol dehydrogenase substrate
0,148  0,030  Antineoplastic, alkylator
0,148  0,031  Carbonic anhydrase XV inhibitor
0,229  0,115  Lipoxygenase inhibitor
0,131  0,017  Phosphodiesterase 6D inhibitor
0,128  0,014  Sphingosine 1-phosphate receptor 4 agonist
0,127  0,013  Alcohol oxidase inhibitor
0,138  0,026  Androgen antagonist
0,128  0,016  NAT1 substrate
0,129  0,019  Antifungal (Aspergillus)
0,137  0,027  Arylamine N-Acetyltransferase substrate
0,128  0,019  Glutathione S-transferase inhibitor
0,116  0,007  S-adenosyl-L-methionine decarboxylase inhibitor
0,125  0,016  Beta tubulin antagonist
0,127  0,019  Keratolytic
0,166  0,059  Antidote
0,131  0,023  SULT1E1 substrate
0,137  0,030  DOPA decarboxylase inhibitor
0,152  0,046  Alkylator
0,145  0,039  Antiviral (Poxvirus)
0,109  0,003  HCV polyprotein inhibitor
0,202  0,097  Cytostatic
0,237  0,132  Antineoplastic (osteosarcoma)
0,130  0,025  Thioredoxin inhibitor
0,122  0,018  Estrogen receptor alpha antagonist
0,118  0,015  Prostaglandin EP2 antagonist
0,144  0,042  Calcium channel N-type blocker
0,109  0,006  Kainate receptor antagonist
0,188  0,087  Histone acetyltransferase inhibitor
0,142  0,041  Contraceptive female
0,119  0,019  Glycine receptor antagonist
0,136  0,036  UGT2B1 substrate
0,160  0,060  Antiparkinsonian, tremor relieving
0,107  0,007  Aconitate hydratase inhibitor
0,108  0,009  Antiviral (Parainfluenza)
0,214  0,116  Antituberculosic
0,143  0,045  Coagulant
0,102  0,005  Squalene epoxidase inhibitor
0,270  0,173  Transcription factor inhibitor
0,133  0,036  Carbonic anhydrase III inhibitor
0,139  0,042  MAO B inhibitor
0,110  0,014  Purinergic P2X1 antagonist
0,123  0,026  Antiviral (Rhinovirus)
0,163  0,066  Antianorexic
0,182  0,087  I kappa B kinase epsilon inhibitor
0,177  0,082  P-glycoprotein inhibitor
0,110  0,016  Glycine receptor agonist
0,114  0,020  Granulocyte macrophage colony stimulating factor agonist
0,254  0,159  CYP2C9 inhibitor
0,101  0,007  MDM2 inhibitor
0,104  0,011  Antimycoplasmal
0,122  0,029  Acetylcholine nicotinic antagonist
0,127  0,034  Nitric-oxide synthase inhibitor
0,106  0,013  Androgen agonist
0,128  0,036  Antiprotozoal (Toxoplasma)
0,143  0,052  Anesthetic local
0,095  0,005  Retinoid X receptor agonist
0,132  0,042  Aldehyde dehydrogenase substrate
0,147  0,056  Cyclooxygenase 2 inhibitor
0,181  0,091  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,145  0,055  Antiprotozoal (Trichomonas)
0,138  0,049  Antineoplastic antimetabolite
0,134  0,045  5 Hydroxytryptamine 3A agonist
0,133  0,044  5-Lipoxygenase inhibitor
0,093  0,004  Dopamine beta hydroxylase inhibitor
0,134  0,045  Aminopeptidase B inhibitor
0,170  0,081  Dual specificity phosphatase 3 inhibitor
0,203  0,114  MAP kinase kinase 3 inhibitor
0,132  0,044  Mucolytic
0,201  0,113  Calpain inhibitor
0,140  0,052  Proteasome inhibitor
0,092  0,005  Kainate receptor 2 antagonist
0,106  0,020  Protein kinase C alpha inhibitor
0,100  0,015  Endocannabinoid uptake inhibitor
0,094  0,009  Heme oxygenase stimulant
0,134  0,049  Menstruation disorders treatment
0,100  0,017  Vanilloid 4 agonist
0,127  0,044  Alpha 2c adrenoreceptor antagonist
0,091  0,008  Postcoital contraceptive
0,116  0,035  Potassium channel activator
0,118  0,036  Calcium antagonist
0,103  0,022  Narcotic antagonist
0,115  0,034  Catalase inhibitor
0,149  0,069  Antidiabetic (type 1)
0,092  0,013  SULT2A1 substrate
0,106  0,027  Na+ K+ transporting ATPase inhibitor
0,177  0,098  Antimitotic
0,133  0,054  Antiviral (Papilloma)
0,177  0,098  Interleukin antagonist
0,107  0,028  Antiprotozoal activity enhancer
0,096  0,017  MAP kinase kinase 7 inhibitor
0,082  0,004  Kainate receptor agonist
0,157  0,079  Heat shock protein 90 alpha antagonist
0,086  0,008  Dihydroorotate oxidase inhibitor
0,127  0,049  Transcription factor STAT6 inhibitor
0,088  0,011  Transcription factor RelA inhibitor
0,164  0,087  Antineoplastic (gastric cancer)
0,092  0,015  Glutamate (mGluR6) antagonist
0,101  0,024  Estrogen-related receptor beta agonist
0,086  0,010  Lysine-specific demethylase 1A inhibitor
0,112  0,036  Paget's disease treatment
0,098  0,021  Carbamoyl phosphate synthetase inhibitor
0,137  0,061  Antihelmintic (Trematoda)
0,100  0,024  Calcium channel L-type blocker
0,121  0,045  Beta glucuronidase inhibitor
0,128  0,052  Alpha 2b adrenoreceptor antagonist
0,099  0,023  CC chemokine 5 receptor agonist
0,122  0,047  Multidrug resistance-associated protein 1 inhibitor
0,102  0,027  Aminopeptidase I inhibitor
0,107  0,033  Glutamate release inhibitor
0,092  0,018  Alpha 2 adrenoreceptor agonist
0,191  0,117  Tumour necrosis factor alpha release inhibitor
0,134  0,060  Epidermal growth factor receptor kinase inhibitor
0,126  0,052  Caspase 3 inhibitor
0,136  0,062  Sphingosine 1-phosphate receptor 2 antagonist
0,093  0,020  Dopamine uptake inhibitor
0,103  0,030  Vanilloid agonist
0,091  0,019  Glutamate (mGluR1) antagonist
0,144  0,072  Sphingosine 1-phosphate receptor 5 antagonist
0,107  0,035  Carbonic anhydrase VI inhibitor
0,121  0,050  Expectorant
0,091  0,020  TRPA1 antagonist
0,095  0,024  Hyperparathyroidism treatment
0,108  0,037  Antifungal (Candida)
0,168  0,097  Antiviral (Influenza)
0,074  0,004  Heme oxygenase inhibitor
0,096  0,026  Neuronal nicotinic receptor antagonist
0,149  0,080  Hexokinase inhibitor
0,088  0,019  Glutamate (mGluR7) antagonist
0,088  0,019  Carbonic anhydrase VB inhibitor
0,117  0,048  Anticataract
0,099  0,031  D-Ala-D-Ala ligase inhibitor
0,218  0,150  CYP3A4 inhibitor
0,078  0,011  Prolyl endopeptidase inhibitor
0,076  0,009  Fructose-1,6-bisphosphatase inhibitor
0,080  0,014  Antiviral (Herpesvirus 3, Human)
0,136  0,070  Interleukin 1 antagonist
0,071  0,005  Sodium-dependent vitamin C transporter 2 inhibitor
0,119  0,054  Choleretic
0,075  0,009  Potassium channel (Inward rectifier) activator
0,218  0,152  ICAM1 expression inhibitor
0,089  0,024  Aromatase inhibitor
0,097  0,033  Histidine decarboxylase inhibitor
0,072  0,009  Retinoid X alpha receptor agonist
0,076  0,012  HCV NS3/NS4A protease inhibitor
0,072  0,009  Potassium channel (ATP-sensitive) activator
0,100  0,038  NAD(P)H dehydrogenase (quinone) inhibitor
0,085  0,023  Protease 3C (Human rhinovirus) inhibitor
0,142  0,081  MAP kinase 3 inhibitor
0,086  0,024  NMDA receptor glycine site agonist
0,104  0,043  Actinic keratosis treatment
0,079  0,017  Dopamine transporter inhibitor
0,091  0,030  Carbonic anhydrase VA inhibitor
0,175  0,114  Antialcoholic
0,082  0,021  Postmenopausal disorders treatment
0,077  0,016  Cyclin B2 inhibitor
0,099  0,038  Carbonic anhydrase XIII inhibitor
0,161  0,100  Amyloid beta aggregation inhibitor
0,103  0,043  Epidermal growth factor antagonist
0,112  0,052  Xanthine oxidase inhibitor
0,071  0,012  Glucose-6-phosphate isomerase inhibitor
0,074  0,014  Glutamate (mGluR group I) agonist
0,186  0,127  Hypoglycemic
0,076  0,017  Protein kinase C theta inhibitor
0,126  0,068  Nav1.3 sodium channel blocker
0,106  0,050  Breast cancer-resistant protein inhibitor
0,065  0,009  Inosine monophosphate dehydrogenase inhibitor
0,081  0,025  Aryl hydrocarbon receptor antagonist
0,065  0,010  Nicotinic acid receptor agonist
0,097  0,042  Contraceptive male
0,140  0,085  Antidiarrheal
0,080  0,025  Argininosuccinate synthase inhibitor
0,081  0,026  5 Hydroxytryptamine 3 agonist
0,064  0,009  GABA uptake inhibitor
0,111  0,057  Mediator release inhibitor
0,086  0,032  Carbonic anhydrase V inhibitor
0,056  0,002  Vesicular glutamate transport inhibitor
0,139  0,085  Acetylcholine M1 receptor antagonist
0,076  0,023  Ornithine carbamoyltransferase inhibitor
0,104  0,051  Glutamate (mGluR7) agonist
0,111  0,059  Antiviral (Coronavirus)
0,111  0,059  Antiviral (SARS coronavirus)
0,063  0,011  Dopamine D5 agonist
0,136  0,084  Antiprotozoal (Coccidial)
0,105  0,054  Sphingomyelinase inhibitor
0,060  0,009  Diamine oxidase inhibitor
0,066  0,015  Glutamate (mGluR5) agonist
0,061  0,010  Guanylate cyclase inhibitor
0,076  0,025  Andropause treatment
0,087  0,037  SULT1A2 substrate
0,083  0,033  Elastase 1 inhibitor
0,061  0,011  Squalene synthetase inhibitor
0,067  0,018  Pregnane X receptor antagonist
0,070  0,021  Nicotinic receptor alpha7 subunit antagonist
0,076  0,027  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,098  0,049  Alpha 2 adrenoreceptor antagonist
0,053  0,005  CYP24 inhibitor
0,056  0,008  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,144  0,096  Mcl-1 antagonist
0,062  0,014  Progesterone antagonist
0,051  0,004  Nicotinic acid receptor 2 antagonist
0,127  0,080  Calcium channel blocker
0,092  0,045  Myeloperoxidase inhibitor
0,067  0,021  Ryanodine receptor antagonist
0,065  0,020  Leukotriene C antagonist
0,089  0,044  Caspase 7 inhibitor
0,054  0,009  Retinoid X receptor antagonist
0,218  0,173  Calpain 2 inhibitor
0,114  0,070  Interleukin 8 antagonist
0,066  0,022  Epithelial sodium channel blocker
0,118  0,073  Antiviral (Hepatitis B)
0,087  0,043  Alpha 2a adrenoreceptor antagonist
0,052  0,008  Vanilloid 3 antagonist
0,063  0,019  Lysophosphatidic acid 3 receptor antagonist
0,112  0,068  Calcium channel (voltage-sensitive) blocker
0,047  0,003  Complement factor 1s inhibitor
0,054  0,011  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,108  0,065  Protein kinase C gamma inhibitor
0,074  0,033  NMDA receptor agonist
0,186  0,145  Amyotrophic lateral sclerosis treatment
0,063  0,023  Nicotinic alpha3beta2 receptor antagonist
0,093  0,052  Histamine N-methyltransferase inhibitor
0,096  0,056  Alpha 2d adrenoreceptor antagonist
0,165  0,124  Aryl hydrocarbon receptor agonist
0,051  0,011  Glutamate (mGluR8) agonist
0,123  0,083  Alkaline phosphatase inhibitor
0,194  0,154  CYP2D6 inhibitor
0,053  0,014  Alpha 1d adrenoreceptor agonist
0,073  0,034  5 Hydroxytryptamine 2A agonist
0,069  0,030  Calcium channel P-type blocker
0,126  0,087  Lipid peroxidase inhibitor
0,061  0,022  Heparanase inhibitor
0,109  0,070  Protein-tyrosine phosphatase 1B inhibitor
0,044  0,006  Nicotinic alpha4beta2 receptor agonist
0,054  0,016  Estrogen receptor alpha agonist
0,052  0,014  Membrane dipeptidase inhibitor
0,047  0,009  Uridine phosphorylase inhibitor
0,046  0,009  Retinoid X alpha receptor antagonist
0,064  0,027  Cyclin B inhibitor
0,064  0,027  Sphingosine kinase 2 inhibitor
0,089  0,052  Antineoplastic antibiotic
0,041  0,004  Imidazoline I1 receptor antagonist
0,072  0,035  HIV-1 integrase (Strand Transfer) inhibitor
0,059  0,022  Nicotinic receptor alpha4 subunit antagonist
0,049  0,014  Potassium channel Kv1.1 blocker
0,081  0,046  Antibiotic
0,133  0,098  Protein-tyrosine phosphatase inhibitor
0,096  0,061  DNA directed RNA polymerase inhibitor
0,073  0,038  Dopamine D1 antagonist
0,105  0,071  GABA receptor agonist
0,092  0,058  Polo-like kinase-1 inhibitor
0,051  0,017  Histamine H1 receptor agonist
0,095  0,061  Bile acid receptor antagonist
0,119  0,085  Toll-Like receptor antagonist
0,055  0,021  Thymidylate synthase inhibitor
0,056  0,023  Aldosterone antagonist
0,049  0,016  Factor XIIIa inhibitor
0,072  0,040  Gaucher disease treatment
0,061  0,028  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,084  0,052  Acetylcholine nicotinic agonist
0,071  0,039  Potassium channel (ATP-sensitive) blocker
0,123  0,092  Antieczematic
0,039  0,007  Kainate receptor 1 antagonist
0,059  0,027  Immunoglobulin Fc receptor antagonist
0,164  0,133  Antiviral (HIV)
0,036  0,005  Vanilloid 2 agonist
0,036  0,005  Fructose-1,6-bisphosphatase 1 inhibitor
0,041  0,010  Adenosine uptake inhibitor
0,035  0,005  ICAM 1 antagonist
0,039  0,009  Sodium/glucose cotransporter 2 inhibitor
0,120  0,090  Antineoplastic (squamous cell carcinoma)
0,118  0,088  Toll-Like receptor 9 antagonist
0,072  0,043  Anticholelithogenic
0,077  0,048  GABA B receptor agonist
0,043  0,014  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,060  0,031  Glucosylceramidase inhibitor
0,138  0,109  Dual specificity phosphatase inhibitor
0,041  0,013  AMPA 3 receptor antagonist
0,044  0,016  Fumarate hydratase inhibitor
0,116  0,088  Nav1.2 sodium channel blocker
0,031  0,004  Retinoid X beta receptor antagonist
0,110  0,084  MAP kinase kinase inhibitor
0,165  0,139  Antiviral (Ebola)
0,051  0,025  Benzodiazepine antagonist
0,057  0,031  Alpha-mannosidase inhibitor
0,094  0,069  Tourette's syndrome treatment
0,083  0,058  GABA A receptor agonist
0,043  0,018  Leukotriene C4 antagonist
0,029  0,005  Neuraminidase (Influenza B) inhibitor
0,058  0,034  CC chemokine 2 receptor antagonist
0,032  0,008  Prostaglandin F2 alpha agonist
0,066  0,042  HIV-1 integrase (3'-Processing) inhibitor
0,046  0,022  Liver X receptor alpha agonist
0,048  0,025  Geranyltranstransferase inhibitor
0,073  0,050  Metalloproteinase-9 inhibitor
0,032  0,009  Sodium/glucose cotransporter 1 inhibitor
0,031  0,008  Inosine monophosphate dehydrogenase 2 inhibitor
0,044  0,021  5-Alpha-reductase inhibitor
0,032  0,009  Glutamate (mGluR1) agonist
0,043  0,020  5 Hydroxytryptamine 2B agonist
0,089  0,066  Alcohol dehydrogenase inhibitor
0,060  0,038  Botulinum neurotoxin type A inhibitor
0,037  0,015  Prostaglandin agonist
0,083  0,061  mTOR complex 2 inhibitor
0,037  0,015  Methionyl aminopeptidase 1 inhibitor
0,032  0,010  Sodium/glucose cotransporter inhibitor
0,073  0,052  Potassium channel (Tandem pore domain) blocker
0,073  0,053  Vanilloid antagonist
0,186  0,165  Antimycobacterial
0,106  0,085  Mental retardation treatment
0,041  0,021  Vesicle monoamine transporter inhibitor
0,032  0,012  Methionyl aminopeptidase 2 inhibitor
0,028  0,008  Monocarboxylic acid transporter inhibitor
0,028  0,008  Monocarboxylic acid transporter 1 inhibitor
0,037  0,017  Melatonin receptor 1A agonist
0,042  0,023  AMPA 4 receptor antagonist
0,025  0,005  Antibiotic Anthracycline-like
0,042  0,023  Retinoic acid alpha receptor agonist
0,073  0,054  Phosphodiesterase VI inhibitor
0,025  0,005  Alpha 2b adrenoreceptor agonist
0,045  0,027  Histamine H2 receptor agonist
0,023  0,005  Nicotinic alpha4 receptor agonist
0,080  0,062  Sleep apnea treatment
0,061  0,044  Adrenaline uptake inhibitor
0,025  0,008  Prostaglandin EP4 agonist
0,031  0,014  Estrogen-related receptor gamma antagonist
0,029  0,012  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,105  0,088  Cholinergic antagonist
0,046  0,029  Dihydroorotase inhibitor
0,066  0,049  Antihemophilic
0,175  0,159  Antineurogenic pain
0,083  0,066  Antileprosy
0,104  0,087  Acetylcholine antagonist
0,050  0,034  CD45 antagonist
0,044  0,028  Nerve growth factor antagonist
0,034  0,018  AMPA 1 receptor antagonist
0,033  0,017  5 Hydroxytryptamine 1D agonist
0,040  0,024  TRPM8 blocker
0,042  0,027  Thymidine kinase inhibitor
0,079  0,064  Antiviral (RSV)
0,068  0,053  Benzodiazepine agonist
0,041  0,026  Dihydropteroate synthase inhibitor
0,029  0,014  Retinoid X gamma receptor antagonist
0,110  0,096  DNA repair enzyme inhibitor
0,059  0,044  Potassium channel intermediate-conductance Ca-activated blocker
0,060  0,046  5 Hydroxytryptamine 5A antagonist
0,023  0,009  Factor XIII inhibitor
0,045  0,031  Mannosidase inhibitor
0,044  0,030  NMDA receptor subunit 3B antagonist
0,083  0,069  Tocolytic
0,023  0,009  Antibiotic Quinolone-like
0,043  0,030  Glutamate (mGluR group III) agonist
0,064  0,051  Acetylcholine M5 receptor agonist
0,074  0,060  Macrophage migration inhibitory factor inhibitor
0,032  0,019  Purinergic P2Y14 antagonist
0,102  0,089  Myasthenia Gravis treatment
0,022  0,009  Alpha 2c adrenoreceptor agonist
0,056  0,043  Fibroblast growth factor 4 antagonist
0,039  0,027  Histone deacetylase 9 inhibitor
0,038  0,026  Antiviral (Bovine viral diarrhea virus)
0,026  0,013  Prostaglandin E2 agonist
0,033  0,021  ATP citrate lysase inhibitor
0,181  0,169  Antipsoriatic
0,091  0,079  Nav1.1 sodium channel blocker
0,038  0,026  Farnesoid X receptor agonist
0,090  0,078  Urease inhibitor
0,022  0,011  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,052  0,040  Leukotriene B4 antagonist
0,029  0,018  Purinergic P2Y15 antagonist
0,031  0,020  Lysophosphatidic acid 2 receptor antagonist
0,024  0,013  Protease (Human cytomegalovirus) inhibitor
0,037  0,026  Histone deacetylase 7 inhibitor
0,024  0,013  Glutamate (mGluR1a) agonist
0,024  0,013  Retinoic acid gamma receptor agonist
0,058  0,048  NMDA 2C receptor antagonist
0,080  0,070  Transcription factor NF kappa B stimulant
0,040  0,030  Plasmepsin II inhibitor
0,014  0,005  Imidazoline I2 receptor antagonist
0,056  0,047  Sphingosine kinase inhibitor
0,035  0,026  5 Hydroxytryptamine 3B antagonist
0,082  0,073  Bromodomain-containing protein 2 inhibitor
0,044  0,036  Adenosine deaminase inhibitor
0,032  0,024  Glutamate (mGluR3) agonist
0,039  0,031  CF transmembrane conductance regulator antagonist
0,019  0,011  Methylmalonyl-CoA mutase inhibitor
0,087  0,080  Cyclin-dependent kinase 9 inhibitor
0,085  0,078  Potassium channel (Voltage-sensitive) activator
0,052  0,045  Xanthine dehydrogenase inhibitor
0,038  0,032  VCAM-1 antagonist
0,027  0,020  NMDA 2D receptor antagonist
0,025  0,019  Acid ceramidase inhibitor
0,038  0,032  VCAM antagonist
0,016  0,010  Thromboxane A2 agonist
0,047  0,041  5 Hydroxytryptamine 2 agonist
0,059  0,052  Leukotriene antagonist
0,061  0,055  Alpha adrenoreceptor agonist
0,013  0,008  Human herpes virus 5 capsid protein P40 inhibitor
0,032  0,027  Glutamate (mGluR4) agonist
0,018  0,013  CXC chemokine 5 receptor antagonist
0,013  0,009  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,025  0,020  Thymidine phosphorylase inhibitor
0,053  0,049  5 Hydroxytryptamine 5 antagonist
0,026  0,022  Hedgehog signaling activator
0,058  0,054  Histone deacetylase SIRT3 inhibitor
0,016  0,012  Carbonic anhydrase VIII inhibitor
0,016  0,012  Carbonic anhydrase X inhibitor
0,040  0,037  Glutamate (mGluR4) antagonist
0,024  0,020  Lysophosphatidic acid receptor 1 agonist
0,026  0,023  Thrombin receptor antagonist
0,026  0,023  LFA antagonist
0,066  0,063  Acetylcholine M4 receptor antagonist
0,016  0,014  Alpha 2a adrenoreceptor agonist
0,016  0,014  Telomerase stimulant
0,084  0,081  MAP kinase kinase 1 inhibitor
0,029  0,026  Cholesterol ester transfer protein antagonist
0,007  0,005  DNA topoisomerase III inhibitor
0,027  0,025  Nicotinic alpha3beta4 receptor agonist
0,067  0,066  Glutamate receptor agonist
0,027  0,026  MAP3K8 inhibitor
0,030  0,029  Calcium release-activated channel blocker
0,020  0,019  GABA transporter inhibitor
0,049  0,048  Bruton tyrosine kinase inhibitor
0,086  0,086  Falcipain 3 inhibitor
0,014  0,014  5-Alpha-reductase 1 inhibitor
0,040  0,040  Dihydrofolate reductase inhibitor
0,014  0,014  Purinergic P2Y1 agonist

